Dr Ana Viñuela
Dr Alison Heggie
Donna McEvoy
Professor Mark Walker
| Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models | 2023 |
|
Dafni Michalettou
Dr Alison Heggie
Donna McEvoy
Professor Mark Walker
Dr Harshal Deshmukh
et al. | Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits | 2023 |
|
Dr Ana Viñuela
Dr Alison Heggie
Donna McEvoy
Professor Mark Walker
| Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study | 2022 |
|
Dr Harshal Deshmukh
Dr Ana Viñuela
Dr Alison Heggie
Professor Mark Walker
| Genome-Wide Association Analysis of Pancreatic Beta-Cell Glucose Sensitivity | 2021 |
|
Dr Ana Viñuela
Dr Alison Heggie
Donna McEvoy
Professor Mark Walker
| Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts | 2020 |
|
Dr Alison Heggie
Donna McEvoy
Dr Ana Viñuela
Professor Mark Walker
| Whole blood co-expression modules associate with metabolic traits and type 2 diabetes: an IMI-DIRECT study | 2020 |
|
Dr Ana Viñuela Rodriguez
Dr Alison Heggie
Emeritus Professor Mark Walker
| Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium | 2019 |
|
Dr Harshal Deshmukh
Dr Alison Heggie
Professor Mark Walker
Dr Ana Viñuela
| Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration | 2019 |
|
Dr Alison Heggie
Professor Mark Walker
| Presentation of new diabetes with severe hypertriglyceridaemia in two young Asian patients | 2015 |
|
